PHOENIX, AZ
Translational Genomics Research Institute Foundation
Quick Facts
- EIN
- 33-1092191
- Location
- PHOENIX, AZ
- Category
- Health
- NTEE Code
- H112
- Total Assets
- $22.8M
- Annual Income
- $11.1M
- Annual Revenue
- $11M
- IRS Ruling Year
- 2004
- Tax Subsection
- 501(c)(03)
About This Organization
Translational Genomics Research Institute Foundation is a nonprofit organization based in PHOENIX, AZ. It received its IRS tax-exempt ruling in 2004. The organization is classified under IRC Section 501(c)(03). It operates in the area of health. Total assets are reported at $22.8M. Annual income is $11.1M. The organization has received $18.8M in foundation grants from 6 funders.
Grants Received from Foundations
Foundation grants awarded to Translational Genomics Research Institute Foundation, based on IRS 990-PF filings.
| Funder | Amount | Year | Purpose |
|---|---|---|---|
| Robert & Lynda Altman Family Foundation | $3M | 2023 | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF |
| Robert & Lynda Altman Family Foundation | $2.7M | 2023 | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECON |
| Foundation For Community And Health Advancement | $44K | 2023 | GRANT AWARD-MIND/CROWD PROJECT |
| Mckesson Foundation | $100 | 2023 | CHARITABLE |
| Robert & Lynda Altman Family Foundation | $4.3M | 2022 | GENERAL PURPOSE |
| Robert & Lynda Altman Family Foundation | $4.3M | 2022 | GENERAL PURPOSE |
| Robert & Lynda Altman Family Foundation | $3.1M | 2022 | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECON |
| Robert & Lynda Altman Family Foundation | $1.3M | 2022 | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF |
| Team Cozzi Foundation | $9K | 2022 | DONATIONS MADE TO TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION |
| Team Cozzi Foundation | $9K | 2022 | DONATIONS MADE TO TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION |
| American Express Foundation | $256 | 2022 | GENERAL SUPPORT |
| American Express Foundation | $256 | 2022 | GENERAL SUPPORT |
| American Express Foundation | N/A | 2022 | GENERAL SUPPORT |
| American Express Foundation | N/A | 2022 | GENERAL SUPPORT |
| Dorrance Family Foundation | $50K | 2021 | TO SUPPORT C4RCD RE-ANALYSIS OF THE PATIENT DATA AND RE-SEQUENCING FOR COLD CASES |
| American Express Foundation | $100 | 2021 | GENERAL SUPPORT |
| American Express Foundation | N/A | 2021 | GENERAL SUPPORT |
| American Express Foundation | N/A | 2021 | GENERAL SUPPORT |
Frequently Asked Questions
What does Translational Genomics Research Institute Foundation do?
Translational Genomics Research Institute Foundation is a nonprofit organization focused on health, based in PHOENIX, AZ. It is classified under IRC Section 501(c)(03).
Who funds Translational Genomics Research Institute Foundation?
Translational Genomics Research Institute Foundation has received foundation grants from Robert & Lynda Altman Family Foundation, Foundation For Community And Health Advancement, Mckesson Foundation, and others.
What is Translational Genomics Research Institute Foundation's annual revenue?
Translational Genomics Research Institute Foundation reports total assets of $22.8M. Annual income is $11.1M.
Where is Translational Genomics Research Institute Foundation located?
Translational Genomics Research Institute Foundation is located in PHOENIX, AZ.
Is Translational Genomics Research Institute Foundation a 501(c)(3)?
Yes, Translational Genomics Research Institute Foundation is a 501(c)(3) tax-exempt organization. Its EIN is 33-1092191. Donations to this organization may be tax-deductible.
Research This Organization
Similar Organizations in Health
Translational Genomics Research Institute
PHOENIX, AZ
Critical Path Institute
TUCSON, AZ
Southwest Autism Research And Resource Center
PHOENIX, AZ
A Race Against Blindness
GILBERT, AZ
Arizona Alzheimers Research Center Inc.
PHOENIX, AZ
National Community Health Partners
CASA GRANDE, AZ
More Organizations in Arizona
Is this your organization?
Claim your profile to add programs, impact data, leadership bios, and earn a Granted Transparency Badge. Verified organizations rank higher in search results.
Claim This Organization